Patent US4195081A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4195081A Expired / Lapsed US ⏱️ 0.0 years remaining

Treating psychic disorders with tetrahydropyridin-4-yl-1H-indoles

Assignee: Sanofi Aventis France
•
Filing: 1979-01-10
•
Granted: 1980-03-25
•
Expires: 1999-01-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel antidepressant, antiemetic and neuroleptic compositions containing as the active ingredient at least one compound of the formula ##STR1## wherein R is selected from the group consisting of hydrogen and methoxy, R 1 and R 2 are individually selected from the group consisting of hydrogen and methyl and their non-toxic, pharmaceutically acceptable acid addition salts and a novel method of treating psychic disorders in warm-blooded animals.

Inventors

  • 👤 Lucien Nedelec
  • 👤 Jacques Guillaume
  • 👤 Claude Dumont

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 10:17
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61P; A61P25/00; A61P25/20; A61P25/24; A61P25/26

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 66 words
A method of treating psychic disorders in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound of the formula ##STR3## wherein R is selected from the group consisting of hydrogen and methoxy, R 1 and R 2 are individually selected from the group consisting of hydrogen and methyl and their non-toxic, pharmaceutically acceptable acid addition salts sufficient to relieve psychic disorders.
Claim 2
Independent Claim 66 words
A method of treating psychic disorders in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound of the formula ##STR3## wherein R is selected from the group consisting of hydrogen and methoxy, R 1 and R 2 are individually selected from the group consisting of hydrogen and methyl and their non-toxic, pharmaceutically acceptable acid addition salts sufficient to relieve psychic disorders.
Claim 3
Dependent Claim 13 words
A method of claim 1 wherein R 1 and R 2 are hydrogen.
Claim 4
Dependent Claim 26 words
A method of claim 1 wherein the active ingredient is selected from the group consisting of 5-methoxy 3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 5
Dependent Claim 25 words
A method of claim 1 wherein the active ingredient is selected from the group consisting of 3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and its non-toxic, pharmaceutically acceptable acid addition salts.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-25 1983-09-24 1984-03-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-25 1987-09-24 1988-03-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-25 1991-09-24 1992-03-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag